If you have had your prostate cancer treated by irreversible electroporation, your experiences could help NICE decide if the procedure should be used more widely in the NHS.
NICE are developing a piece of Interventional Procedures Guidance: Irreversible electroporation for treating prostate cancer [IP1020/2]. As part of this, they want to hear from patients who have already had the procedure by 17 June 2022.
The National Institute for Health and Care Excellence (NICE) is carrying out a project on the procedure ‘Irreversible electroporation for treating prostate cancer.’ They are looking at how well the procedure is working and if it is safe enough to be used more widely in the NHS in the future.
The prostate is a gland at the base of a man’s bladder which surrounds the tube (urethra) leading from the bladder to the outside. Prostate cancer is often diagnosed before symptoms develop, but it may present with problems in passing urine or difficulties with sexual function. In this procedure, single-use needles are inserted into the prostate. Short electrical pulses of high-voltage current are passed between the needles to create tiny holes (pores) in the cancer cells (irreversible electroporation). The aim is to kill the cancer cells without damaging the structure of the prostate.
If this is a procedure that you have had, NICE would like to invite you to provide feedback on your experience of it by completing this survey, which should take no more than 10 minutes to complete. If this is a procedure that you have not had, please do not complete this survey.
If you would like to find out more about NICE or the programme please visit their website. For assistance or advice on completing this questionnaire, please email [email protected] or call 0161 870 3020.
Take the patient questionnaire